BDSI - addiction contract











































What's your basis for claiming "delay"? A very recent investor event had no mention of any delay - in fact the national sales meeting was mentioned and that sales reps would be ready to go immediately after that.

To those who seem to be saying that the product has terrible head-winds against Suboxone... BDSI doesn't need to capture 50% of the market to be successful with this. Their own targets say if they can penetrate 25% (*shared* with Zubsolv), that'd be huge for them - $250M. This is a 1.7B market and growing, so there is room for even smaller competitors to do well. Sounds like the perks are pretty good for the reps - GLTA.
 












even 2% on 2B market = $800k/rep top line @ 50 rep (planned force, I believe, for BDSI). Zubsolv's sales are going the right direction, too.

As a sales rep, why not look at it as an opportunity to do what you do best: sell. Prove the doubters wrong. (But I realize you're likely a Suboxone rep, so I understand your position...)
 






even 2% on 2B market = $800k/rep top line @ 50 rep (planned force, I believe, for BDSI). Zubsolv's sales are going the right direction, too.

As a sales rep, why not look at it as an opportunity to do what you do best: sell. Prove the doubters wrong. (But I realize you're likely a Suboxone rep, so I understand your position...)

Told us a few more weeks - no problem - be prepared
 


















It may not. RB is suing BDSI for patent infringement...they tried a year ago, but the judge tossed it out bc they couldn't sue a product that wasn't FDA approved yet. Expect them to come at BDSI with a lot of legal backing. BDSI is definitely taking a risk by launching, but they must feel confident that their technology is just a bit different enough to avoid patent infringement.
 






It may not. RB is suing BDSI for patent infringement...they tried a year ago, but the judge tossed it out bc they couldn't sue a product that wasn't FDA approved yet. Expect them to come at BDSI with a lot of legal backing. BDSI is definitely taking a risk by launching, but they must feel confident that their technology is just a bit different enough to avoid patent infringement.

Actually BDSI is suing RB. Doubt this will launch before the end of the year. I hope they keep us on payroll.
 






Actually BDSI is suing RB. Doubt this will launch before the end of the year. I hope they keep us on payroll.

Not sure either. I'm getting a little nervous. BDSI is suing RB claiming their suit is invalid.
I'm assuming we're not wanting to launch at risk now? I'm hoping they'll keep us on payroll if that is the case.
 
























  • cafead   Sep 24, 2014 at 08:08: AM
café makes $$ off ads. they would inflate views is my guess

The number of views does not necessarily indicate that 18,000 different users have viewed the thread, just that it was viewed 18,000 times. There can be multiple views per user. For instance, if 100 users viewed the thread every time there was a new post, since there are over 100 posts, it would be over 10,000 views.

Cafepharma does not inflate pageviews. We use Google's enterprise-level ad server to rotate ads, and they have sophisticated algorithms for detecting view inflation. This can assure our advertisers and our users that our pageviews are not artificially inflated. Since we receive in excess of 7 million pageviews each month, views on threads of interest can add up quickly.